Previous Issue
Volume 36, FIT Cancer 10
 
 
msf-logo

Journal Browser

Journal Browser

Med. Sci. Forum, 2025, CiiEM 2025

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Number of Papers: 3
Order results
Result details
Select all
Export citation of selected articles as:

Other

6 pages, 186 KiB  
Proceeding Paper
A One Health Perspective on the Clinical, Behavioural, and Environmental Risks of Chronic Proton Pump Inhibitor Use in Older Adults
by Maria Deolinda Auxtero
Med. Sci. Forum 2025, 37(1), 1; https://doi.org/10.3390/msf2025037001 - 18 Aug 2025
Abstract
This study explores the clinical, behavioural, and environmental risks of chronic proton pump inhibitor (PPI) use in older adults through a One Health perspective. Among 246 participants, 32.5% were receiving PPI therapy, with 91.3% on long-term treatment, frequently lacking clear clinical justification. Polypharmacy, [...] Read more.
This study explores the clinical, behavioural, and environmental risks of chronic proton pump inhibitor (PPI) use in older adults through a One Health perspective. Among 246 participants, 32.5% were receiving PPI therapy, with 91.3% on long-term treatment, frequently lacking clear clinical justification. Polypharmacy, drug interactions, and risky lifestyle behaviours were common. Environmental review highlighted the potential persistence of PPI transformation products in water systems, raising concerns about ecological impact and antimicrobial resistance. These findings underscore the urgency of implementing deprescribing strategies, enhancing patient education, and adopting sustainable prescribing practices that align human and environmental health. Full article
5 pages, 201 KiB  
Proceeding Paper
Attitudes Toward Community Service Among Higher Health Sciences Students
by Sónia Vicente, Ângela Maria Pereira, Ana Cristina Vidal and Cláudia Maria Costa
Med. Sci. Forum 2025, 37(1), 2; https://doi.org/10.3390/msf2025037002 - 19 Aug 2025
Abstract
University Social Responsibility (USR) integrates academic goals with ethics, civic engagement, and sustainability. This study assessed community service attitudes among 529 higher health sciences students using the Portuguese Community Service Attitudes Scale. Although 52.9% reported prior volunteer experience, 75.2% had not participated in [...] Read more.
University Social Responsibility (USR) integrates academic goals with ethics, civic engagement, and sustainability. This study assessed community service attitudes among 529 higher health sciences students using the Portuguese Community Service Attitudes Scale. Although 52.9% reported prior volunteer experience, 75.2% had not participated in community service during university. An association was found between academic programme and prior involvement, particularly among Dental Medicine and Physiotherapy students. While no sex differences were observed, programme-specific trends suggest that practical training fosters stronger civic responsibility. Integrating structured, discipline-specific community service into curricula may enhance civic identity and better align education with sustainable development goals. Full article
5 pages, 475 KiB  
Proceeding Paper
Pharmaceutical Profiling of Fentanyl Use in Portugal: Consumption Patterns and Abuse Deterrence Gaps
by Ana Isabel Fernandes
Med. Sci. Forum 2025, 37(1), 3; https://doi.org/10.3390/msf2025037003 - 19 Aug 2025
Abstract
Fentanyl, a potent synthetic opioid used in pain management, has seen a marked rise in outpatient use in Portugal between 2015 and 2022. During this period, consumption nearly doubled, with transdermal patches and sublingual tablets dominating the market. Rapid-onset formulations lacking abuse-deterrent features [...] Read more.
Fentanyl, a potent synthetic opioid used in pain management, has seen a marked rise in outpatient use in Portugal between 2015 and 2022. During this period, consumption nearly doubled, with transdermal patches and sublingual tablets dominating the market. Rapid-onset formulations lacking abuse-deterrent features pose have heightened the risks of misuse and diversion. Despite these concerns, no abuse-deterrent fentanyl products are currently available in Portugal. These findings expose critical regulatory and pharmaceutical gaps. To mitigate public health and environmental risks, a coordinated strategy—encompassing prescription monitoring, education, safer formulations, and a One Health approach—is urgently needed to ensure responsible opioid use and stewardship. Full article
Show Figures

Figure 1

Previous Issue
Back to TopTop